- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06262529
Neurocognitive Impairment After Ischemic Stroke (COG-TRA-Y MRI)
Trajectories of Neurocognitive Impairment After Ischemic Stroke in Young Subjects
Affecting more than 150,000 patients in France, stroke is a major public health issue and a leading cause of disability worldwide. In western countries, 80-85% of strokes are of ischemic subtype. This study will focus on young adults, aged 18-45, with a diagnosis of ischemic stroke.
Studies assessing post-stroke cognition in young patients reported an alarming prevalence of cognitive impairment, affecting about 60% of stroke survivors between 4 and 12 months after the acute event. However, longitudinal data on neurocognitive trajectories (i.e., the evolution of cognitive impairment over time) in young patients with ischemic stroke are lacking. Collecting such data requires an exhaustive neuropsychological assessment and several functional evaluations, at different times, for the same patient.
Repeated neurocognitive study of young patients with ischemic stroke will enable: a description of the prevalence of impaired global cognitive efficiency, an analysis of the specific neurocognitive domains affected, and the tracing of trajectories of recovery from cognitive impairment over time, in terms of global cognitive efficiency and as a function of specific neurocognitive domains (memory, executive, attentional, social cognition, instrumental functions, fatigability, etc.).
Up to date, the clinic-radiological predictors and associated factors of neurocognitive impairment after ischemic stroke in young patients have not been studied. Ischemic stroke causes acute brain lesions of the gray matter (GM) and white matter (WM). Numerous studies suggest that cognitive health may be more closely linked to the integrity of WM than to GM. Magnetic resonance imaging (MRI), and in particular diffusion tensor imaging (DTI) sequences, analyze WM bundles. By using fiber tracking algorithms image analysis enable the WM fiber bundle reconstruction and allow quantifying the volume of lesions (pre-existing and ischemic stroke-induced) in the WM tract.
The aim of this study is to study whether the extension of pre-existing and acute white matter lesions is associated with poorer cognitive recovery after ischemic stroke, both in terms of global cognitive performance and impairment in specific neurocognitive domains.
Study Overview
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Marina Passalboni
- Phone Number: 04 92 03 27 90
- Email: passalboni.m@chu-nice.fr
Study Contact Backup
- Name: Barbara CASOLLA
- Phone Number: 04 92 03 27 90
- Email: casolla.b@chu-nice.fr
Study Locations
-
-
-
Cannes, France, 06600
- Not yet recruiting
- cannes Hospital
-
Contact:
- sylvain LACHAUD
- Email: s.lachaud@ch-cannes.fr
-
Principal Investigator:
- Sylvain Lachaud
-
Nice, France, 06000
- Recruiting
- Nice University Hospital
-
Contact:
- Marina Passalboni
- Phone Number: 04 92 03 27 90
- Email: passalboni.m@chu-nice.fr
-
Principal Investigator:
- barbara CASOLLA
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age: 18 to 45 years.
- Pathology: ischemic stroke diagnosed with brain MRI as per standard clinical practice, with or without occlusion of proximal artery, anterior or posterior circulation.
- Ability to understand and complete study tests and questionnaires: fluent French speaker and reader.
- All patients must be affiliated to a social security scheme.
- Signature of informed consent form.
Exclusion Criteria:
- Pre-existing cognitive impairment (defined as CQI <78 or clinical dementia).
- Severe functional dependence prior to stroke (defined as Modified Rankin Scale MRS = score 5).
- Any neurological or psychiatric comorbidity.
- Sensory disorders: visual impairment, blindness, deafness.
- Severe acquired phasic disorders: on the expressive oral side, in the presence of an inability to express oneself, which interferes with the collection of responses to neuropsychological tests; and on the receptive oral side, in the presence of an inability to understand the instructions of neuropsychological tests. Phasic functioning is systematically assessed during hospitalization by means of the NIHSS (score ≤ 2 on the "Language" sub-test), and will be rechecked clinically and psychometrically during neuropsychological assessments using the Language Screening Test (LAST) for both expression and oral comprehension. - Severe motor disorders: inability to mobilize the dominant upper limb for written neuropsychological tests.
- Contraindication to MRI.
- Pregnant women.
- HIV-positive patients: interaction of infectious pathology on cognitive functioning. Declarative, no HIV tests will be performed.
- Withdrawal of informed consent.
- Consumption of alcohol and/or narcotics on the day of neuropsychological assessments.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Acute ischemic stroke
|
Cerebral MRI at 72h / 3 months / 12 months
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
evolution of neurocognitive disorders (trajectories of global cognitive efficiency) over 1 year after stroke
Time Frame: Between 3 months and 12 months
|
Montréal cognitive assessment (MOCA - score 0 to 30)
|
Between 3 months and 12 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 22-AOI-06
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Ischemic Stroke
-
University of CalgaryThe George Institute for Global Health, AustraliaNot yet recruitingAcute Ischemic Stroke AIS | Stroke, Acute, Stroke Ischemic | Stroke AcuteCanada, Australia
-
Second Affiliated Hospital, School of Medicine,...Shanghai Zhongshan Hospital; First Affiliated Hospital of Wenzhou Medical University and other collaboratorsRecruitingAcute Ischemic Stroke and Transient Ischemic AttacksChina
-
Dongzhimen Hospital, BeijingThe Second Hospital of Hebei Medical University; Peking University Third Hospital and other collaboratorsRecruitingStroke, Ischemic | Stroke, Acute | Acute Ischemic StrokeChina
-
University of MiamiTemporarily not availableStroke, Ischemic | Stroke, Acute | Mesenchymal Stem Cells | Acute Ischemic Stroke | Stroke/Brain AttackUnited States
-
The University of Texas Health Science Center,...National Center for Advancing Translational Sciences (NCATS)CompletedAcute Ischemic Stroke (AIS)United States
-
Beijing Tiantan HospitalRecruitingIschemic Stroke, AcuteChina
-
Shanghai Yueyang Integrated Medicine HospitalRecruitingIschemic Stroke, AcuteChina
-
Beijing Tiantan HospitalCompletedIschemic Stroke, AcuteChina
-
Anaconda Biomed S.L.Not yet recruitingAcute Ischemic Stroke From Large Vessel Occlusion
-
Centre Hospitalier Sud FrancilienCompletedAcute Ischemic Stroke Due to Medium-vessel-occlusionFrance
Clinical Trials on Cerebral MRI
-
Fondation Ophtalmologique Adolphe de RothschildRecruiting
-
Fondation Ophtalmologique Adolphe de RothschildRecruitingBenign Neuronal DeseaseFrance
-
Fondation Ophtalmologique Adolphe de RothschildActive, not recruiting
-
IRCCS San RaffaeleRecruiting
-
Hospices Civils de LyonRecruitingChildren With Cerebral PalsyFrance
-
University Hospital, Strasbourg, FranceRecruiting
-
Vienna Institute for Research in Ocular SurgeryCompletedRetinal Artery OcclusionAustria
-
Assistance Publique - Hôpitaux de ParisRecruitingCadasil | Angiopathy; CerebralFrance
-
Fondation Ophtalmologique Adolphe de RothschildCompletedPathologic Processes | Multiple Sclerosis | Magnetic Resonance Imaging | Prognosis | Tomography, Optical CoherenceFrance
-
Hospices Civils de LyonRecruiting